OTCMKTS:TRSSF TerrAscend (TRSSF) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free TRSSF Stock Alerts $1.59 -0.05 (-3.32%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$1.57▼$1.7050-Day Range$1.54▼$2.0752-Week Range$1.62▼$1.80Volume168,149 shsAverage Volume131,026 shsMarket Capitalization$399.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC Filings Get TerrAscend alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About TerrAscend Stock (OTCMKTS:TRSSF)TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.Read More TRSSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRSSF Stock News HeadlinesOctober 21, 2023 | benzinga.comTerrAscend Corp Stock (OTC:TRSSF), Short Interest ReportOctober 19, 2023 | msn.comWhich Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? September 28, 2023 | markets.businessinsider.comEXCLUSIVE: Why TerrAscend's Success Doesn't Rely On Federal Cannabis ReformSeptember 12, 2023 | benzinga.com7TRSSF : Why 280e Change Spells Good...September 11, 2023 | benzinga.comMajor Capital Market Crisis In Cannabis Industry? Here's What TerrAscend's Jason Wild SaysAugust 25, 2023 | benzinga.comThis US Cannabis Stock Is No Longer At The Mercy Of U.S. Regulations, Here's WhyAugust 14, 2023 | benzinga.comTerrAscend Delighted About Maryland's Cannabis Sales, Meet Exec Chair Jason Wild At Benzinga Conference In ChicagoApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? July 21, 2023 | fool.comTerrAscend (OTC: TRSSF)July 6, 2023 | finance.yahoo.comTerrAscend Announces Symbol Change on OTC Markets to TSNDFJuly 4, 2023 | proactiveinvestors.comTerrAscend shares start trading on the Toronto Stock ExchangeJuly 4, 2023 | finance.yahoo.comTerrAscend (TSX: TSND) Commences Trading on the TSXJuly 3, 2023 | markets.businessinsider.comTerrAscend To Acquire Herbiculture, Adding A Fourth Dispensary In MarylandJune 30, 2023 | finance.yahoo.comTerrAscend Closes on Third Dispensary Acquisition in Maryland Ahead of Adult-Use LaunchJune 30, 2023 | finance.yahoo.comTerrAscend Increases Footprint in Maryland to Four Dispensaries with Agreement to Acquire Herbiculture, Transaction Already Approved by Maryland RegulatorJune 30, 2023 | msn.comTerrAscend Completes $37M Paydown Of Senior Secured Term Loan In PennsylvaniaJune 30, 2023 | msn.comTerrAscend completes paydown of $37M senior secured term loanJune 30, 2023 | finance.yahoo.comTerrAscend Announces $37 Million Paydown of Senior Secured Term Loan in PennsylvaniaJune 29, 2023 | markets.businessinsider.comFirst American Marijuana MSO To Trade On TSX: TerrAscend Becomes 'Truly Independent'June 29, 2023 | finance.yahoo.comTerrAscend Declares its IndependenceJune 28, 2023 | msn.comTerrAscend Closes Acquisition Of Top Performing Maryland Cannabis Dispensary, Peninsula Alternative HealthJune 28, 2023 | finance.yahoo.comTerrAscend Closes on Acquisition of Top Performing Maryland Dispensary, Peninsula Alternative HealthJune 28, 2023 | markets.businessinsider.comTerrAscend Secures $20.5M Via Second Tranche Of Private PlacementsJune 28, 2023 | financialpost.comTerrAscend Closes on Second Tranche of Private Placements for Total Aggregate Proceeds of US$20.5 MillionJune 27, 2023 | msn.comTerrAscend Expands Retail Footprint In Maryland With Acquisition Of Blue Ridge WellnessJune 27, 2023 | finance.yahoo.comTerrAscend Closes US$25 Million Commercial Loan with Stearns BankSee More Headlines Receive TRSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/16/2021Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Agricultural production - crops Sub-IndustryN/A Current SymbolOTCMKTS:TRSSF CUSIPN/A CIK1778129 Webwww.terrascend.com Phone(855) 837-7295FaxN/AEmployees1,125Year Founded2017Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-329,910,000.00 Net Margins-125.03% Pretax Margin-114.03% Return on Equity-6.66% Return on Assets-3.07% Debt Debt-to-Equity Ratio0.55 Current Ratio0.73 Quick Ratio0.40 Sales & Book Value Annual Sales$247.83 million Price / Sales1.61 Cash FlowN/A Price / Cash FlowN/A Book Value$1.28 per share Price / Book1.24Miscellaneous Outstanding Shares251,860,000Free Float168,925,000Market Cap$399.37 million OptionableNot Optionable Beta2.89 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Jason Garrett Wild R.Ph. (Age 50)Exec. Chairman Comp: $500kMr. Ziad Ghanem (Age 45)Pres & CEO Comp: $587kMr. Keith Stauffer (Age 53)Chief Financial Officer Comp: $549.87kMs. Lynn Gefen (Age 51)Chief Legal Officer & Corp. Sec. Comp: $394.18kMr. David WheelerSr. VP & Chief Information OfficerMr. Matthew Chesler C.F.A.Head of Investor RelationsMr. Charles OsterSr. VP of SalesMr. Jeroen De BeijerChief People & Culture OfficerMr. Jared AndersonSr. VP of Fin. & StrategyKarim BouazizPres of the Northeast RegionMore ExecutivesKey CompetitorsTerrAscendOTCMKTS:TSNDFGrown Rogue InternationalOTCMKTS:GRUSFCommunity Health SystemsNYSE:CYHADC TherapeuticsNYSE:ADCTLarimar TherapeuticsNASDAQ:LRMRView All Competitors TRSSF Stock Analysis - Frequently Asked Questions Should I buy or sell TerrAscend stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TRSSF shares. View TRSSF analyst ratings or view top-rated stocks. How have TRSSF shares performed in 2024? TerrAscend's stock was trading at $1.63 on January 1st, 2024. Since then, TRSSF stock has decreased by 2.7% and is now trading at $1.5857. View the best growth stocks for 2024 here. How were TerrAscend's earnings last quarter? TerrAscend Corp. (OTCMKTS:TRSSF) announced its quarterly earnings results on Tuesday, November, 16th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.29. TerrAscend had a negative trailing twelve-month return on equity of 6.66% and a negative net margin of 125.03%. How do I buy shares of TerrAscend? Shares of TRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TRSSF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TerrAscend Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
